Long, G. V., Larkin, J., Schadendorf, D., Grob, J., Lao, C. D., Marquez-Rodas, I., Wagstaff, J., Lebbé, C., Pigozzo, J., Robert, C., Ascierto, P. A., Atkinson, V., Postow, M. A., Atkins, M. B., Sznol, M., Callahan, M. K., Topalian, S. L., Sosman, J. A., Kotapati, S., Thakkar, P. K., Ritchings, C., Benito, M. P., Re, S., Soleymani, S., Hodi, F. S. (2025). Pooled Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone in Patients With Advanced Melanoma. Journal of Clinical Oncology. https://doi.org/10.1200/jco.24.00400